October 24, 2012 at 17:20 PM EDT
Alkermes' Breakout Falls Victim To Market Correction
A breakout from biomedical issue Alkermes (ALKS) has fizzled, thanks to the market's turn for the worse. Another drug company with operations in Ireland, Jazz Pharmaceuticals (JAZZ), is in much better shape. Alkermes ended Wednesday below its 50-day moving average for the fourth straight day and is on track to post its third straight weekly loss. That's not what one would have expected Sept. 20, when it broke out from a flat base. By the time the
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here